Carefully monitored levothyroxine suppressive therapy is not associated with bone loss in premenopausal women

Journal of Clinical Endocrinology and Metabolism

Volumn 78, Issue 4, 1994, Pages 818-823

  Marcocci, Claudio ^a   Golia, Franco ^a   Bruno Bossio, Gabriella ^a   Vignali, Edda ^a   Pinchera, Aldo ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; COLLAGEN TYPE 1; LEVOTHYROXINE; LIOTHYRONINE; OSTEOCALCIN; PARATHYROID HORMONE; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; SEX HORMONE BINDING GLOBULIN; THYROTROPIN;

ADULT; ARTICLE; BONE ATROPHY; BONE DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; FEMUR NECK; FREE THYROXINE INDEX; GOITER; HUMAN; LIOTHYRONINE BLOOD LEVEL; LUMBAR SPINE; PREMENOPAUSE; PRIORITY JOURNAL; THYROID CANCER; THYROIDECTOMY;

ADULT; BONE DENSITY; CALCIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GOITER; HUMAN; MIDDLE AGE; OSTEOCALCIN; OSTEOPOROSIS; PARATHYROID HORMONES; PREMENOPAUSE; PROCOLLAGEN; SEX HORMONE-BINDING GLOBULIN; SUPPORT, NON-U.S. GOV'T; THYROID NEOPLASMS; THYROTROPIN; THYROXINE; TIME FACTORS; TRIIODOTHYRONINE;

EID: 0028350571     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem.78.4.8157704     Document Type: Article

References (41)

1. Mosekilde L, Eriksen EF, Charles P. 1990 Effects of thyroid hormones on bone and mineral metabolism. Endocrinol Metab Clin North Am. 19:35-63.
2. Mosekilde L, Melsen F, Bagger JP, Myhere-Jensen O, Sorensen NS. 1977 Bone changes in hyperthyroidism. Interrelationship between bone morphometry, thyroid function and calcium-phosphorus metabolism. Acta Endocrinol (Copenh). 85:515-525.
3. Wartofsky L. 1988 Osteoporosis: a growing concern for the thyroi-dologist. Thyroid Today. 11:1-11.
4. Toh SH, Claunch BC, Brown PH. 1985 Effect of hyperthyroidism and its treatment on bone mineral content. Arch Intern Med. 145:883-886.
5. Lee MS, Kim SY, Lee CM, et al. 1990 Negative correlation between the change in bone mineral density and serum osteocalcin in patients with hyperthyroidism. J Clin Endocrinol Metab. 70:766-770.
6. Marcocci C, Catalano F, Schipani E, et al. 1990 Effects of thyrotoxicosis and long-term lévothyroxine therapy on appendicular bone density in premenopausal women. In: De Bastiani G, Pecile A, Pietrogrande V, Torri G, eds. Osteoporoses and their treatment. Monduzzi Editore, Bologna, 37-43.
7. Ross DS, Neer RM, Ridgway EC, Daniels, GH. 1987 Subclinical hyperthyroidsm and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with L-thyroxine. Am J Med. 82:1167-1170.
8. Paul TL, Kerrigan J, Kelly AM, Braverman LE, Baran DT. 1988 Long-term L-thyroxine is associated with decreased hip bone density in premenopausal women. JAMA. 259:3137-3141.
9. Taelman P, Kaufman JM, Janssens X, Vandecauter H, Vermeulen V 1990 Reduced forearm bone mineral content and biochemical evidence of increased bone turnover in women with euthyroid goiter treated with thyroid hormone. Clin Endocrinol (Oxf). 33:107-117.
10. Diamond T, Nery L, Hales Y. 1990 A therapeutic dilemma: suppressive doses of thyroxine reduce bone mineral measurements in both premenopausal and postmenopausal women with thyroid carcinoma. J Clin Endocrinol Metab. 72:1184-1188.
11. Stall GM, Harris S, Sokoll LJ, Dawson-Hughes B. 1990 Accelerated bone loss in hypothyroid patients overtreated with L-thyroxine. Ann Intern Med. 113:265-269.
12. Ribot C, Tremollieres F, Pouilles JM, Louvet JP. 1990 Bone mineral density and thyroid hormone therapy. Clin Endocrinol (Oxf). 33:143-153.
13. Greenspan SL, Greenspan FS, Resnick NM, Block JE, Friedlander AL, Gênant HK. 1991 Skeletal integrity in premenopausal and postmenopausal women receiving long-term L-thyroxine therapy. Am J Med. 91:5-14.
14. Gam AN, Jensen GF, Hasselstrom K, Olsen M, Nielsen KS. 1991 Effect of thyroxine therapy on bone metabolism in substituted hypothyroid patients with normal or suppressed levels of TSH. J Endocrinol Invest. 14:451-455.
15. Franklin JA, Betteridge J, Daykin J, et al. 1992 Long-term thyroxine treatment and bone mineral density. Lancet. 340:9-13.
16. Baran DT, Bravermann LE. 1991 Editorial: thyroid hormone and bone mass. J Clin Endocrinol Metab. 72:1182-1183.
17. Franklin JA, Sheppard MC. 1992 The thyroid and osteoporosis. Trends Endocrinol Metab. 3:113-116.
18. Surks MI, Chopra IJ, Mariash CN, Nicoloff JT, Solomon DH. 1990 American Thyroid Association guidelines for use of laboratory tests in thyroid disorders. JAMA. 263:1529-1532.
19. Editorial. 1990 Thyroxine replacement therapy: too much of a good thing? Lancet. 336:1352-1353.
20. Martino E, Bambini G, Bartalena L, et al. 1986 Human thyrotropin measurement by ultrasensitive immunoradiometric assay as a first-linextest in the evaluation of thyroid function. Clin Endocrinol (Oxf). 24:141-146.
21. Rosner W, Aden DP, Khan MS. 1984 Hormonal influences on the secretion of steroid-binding proteins by a human hepatoma-derived cell line. J Clin Endocrinol Metab. 59:806-809.
22. Faber J, Korslev-Petersen K, Perrild H, Lorenzen I.1990 Different effects of thyroid disease on serum levels of procollagen III, N-peptide and hyaluronic acid. J Clin Endocrinol Metab. 71:1016-1021.
23. Risteli J, Elomaa I, Niemi S, Novamo A, Risteli L. 1993 Radioimmunoassay for the pyridoline cross-linked carboxyterminal telo-peptide of type I collagen: A new serum marker of bone resorption. Clin Chem. 39:635-640.
24. Burman KD. 1990 Is long-term lévothyroxine therapy safe? Arch Intern Med. 150:2010-2013.
25. Utiger RD. 1990 Therapy of hypothyroidism: when are changes needed? N Engl J Med. 323:126-127.
26. Robbins J, Merino MJ, Boice Jr JD, et al. 1991 Thyroid cancer: a lethal endocrine neoplasm. Ann Intern Med. 115:133-147.
27. Berghout A, Wiersinga WM, Drexhage HA, Smits NJ, Touber JL. 1990 Comparison of placebo with L-thyroxine alone or with carbimazole for treatment of sporadic non-toxic goiter. Lancet. 336:193-197.
28. Ross DS. 1992 Thyroid hormone suppressive therapy of sporadic nontoxic goiter. Thyroid. 2:263-269.
29. Sawin CT, Geller A, Hershman JM, Castelli W, Bacharach P. 1989 The ageing thyroid: the use of thyroid hormone in older persons. JAMA. 261:2653-2655.
30. Gow SM, Caldwell G, Tofd AD, et al. 1987 Relationship between pituitary and other target organ responsiveness in hypothyroid patients receiving thyroxine replacement. J Clin Endocrinol Metab. 64:364-370.
31. Toft AD. 1991 Thyroxine replacement therapy. Clin Endocrinol (Oxf). 34:103-105.
32. Editorial. 1990 Thyrotoxicosis and the hearth: something old and something new. J Clin Endocrinol Metab. 7:332-333.
33. Pioli G, Pedrazzoni M, Palummeri E, et al. 1992 Longitudinal study of bone loss after thyroidectomy and suppressive therapy in premenopausal women. Acta Endocrinol (Copenh). 126:238-242.
34. Krolner B, Vesterdal Jorgensen J, Pors Nielsen S. 1983 Spinal bone mineral content in mixedema and thyrotoxicosis. Effects of thyroid hormone(s) and antithyroid treatment. Clin Endocrinol (Oxf). 18:439-446.
35. Toh SH, Brown PH. 1990 Bone mineral content in hypothyroid male patients with hormone replacement: a 3-year study. J Bone Mineral Res. 5:463-467.
36. Ross DS. 1992 Bone density is not reduced during the short-term administration of lévothyroxine to post-menopausal women with subclinical hypothyroidism. A randomized prospective study [Abstract], Thyroid [Suppl 1] 2:S-37.
37. Ross DS. 1991 Monitoring L-thyroxine therapy: lesson from the effects of L-thyroxine on bone density. Am J Med. 91:1-4.
38. Leese GP, Jung RT, Guthrie C, Waugh N, Browing MCK. 1992 Morbidity in patients on L-thyroxine: a comparison of those with a normal TSH to those with a suppressed TSH. Clin Endocrinol (Oxf). 37:500-504.
39. Bartalena L, Martino L, Pacchiarotti A, et al. 1987 Factors affecting suppression of endogenous thyrotropin secretion by thyroxine replacement: retrospective analysis in athyreotic and goitrous patients. J Clin Endocrinol Metab. 64:849-855.
40. Ross DR, Ardisson LJ, Nussbaum SR, Meskell MJ. 1991 Serum osteocalcin in patients taking L-thyroxine who have subclinical hyperthyroidism. J Clin Endocrinol Metab. 72:507-509.
41. Harvey RD, McHardy KC, Reid IW, et al. 1991 Measurement of bone collagen degradation in hyperthyroidism and during thyroxine replacement therapy using pyridinium cross-links as specific urinary markers. J Clin Endocrinol Metab. 72:1189-1194.